Cargando…
Liver Fibrosis and Steatosis in Alström Syndrome: A Genetic Model for Metabolic Syndrome
Alström syndrome (ALMS) is an ultra-rare monogenic disease characterized by insulin resistance, multi-organ fibrosis, obesity, type 2 diabetes mellitus (T2DM), and hypertriglyceridemia with high and early incidence of non-alcoholic fatty liver disease (NAFLD). We evaluated liver fibrosis quantifying...
Autores principales: | Bettini, Silvia, Bombonato, Giancarlo, Dassie, Francesca, Favaretto, Francesca, Piffer, Luca, Bizzotto, Paola, Busetto, Luca, Chemello, Liliana, Senzolo, Marco, Merkel, Carlo, Angeli, Paolo, Vettor, Roberto, Milan, Gabriella, Maffei, Pietro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8170882/ https://www.ncbi.nlm.nih.gov/pubmed/33924909 http://dx.doi.org/10.3390/diagnostics11050797 |
Ejemplares similares
-
Case Report:Pregnancy and birth in a mild phenotype of Alström syndrome
por: Marozio, Luca, et al.
Publicado: (2022) -
Adipogenic progenitors in different organs: Pathophysiological implications
por: Favaretto, Francesca, et al.
Publicado: (2021) -
Brain involvement in Alström syndrome
por: Citton, Valentina, et al.
Publicado: (2013) -
Consensus clinical management guidelines for Alström syndrome
por: Tahani, Natascia, et al.
Publicado: (2020) -
SGLT2 Inhibitors in the Management of Type 1 Diabetes (T1D): An Update on Current Evidence and Recommendations
por: Maffei, Pietro, et al.
Publicado: (2023)